| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0165-4608(85)90016-0 |
| P698 | PubMed publication ID | 3891074 |
| P2093 | author name string | Van den Berghe H | |
| Mecucci C | |||
| Barbieri D | |||
| Vermaelen K | |||
| Tricot G | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 189-255 | |
| P577 | publication date | 1985-07-01 | |
| P1433 | published in | Cancer Genetics and Cytogenetics | Q15753061 |
| P1476 | title | The 5q-anomaly | |
| P478 | volume | 17 |
| Q67933474 | 5 q-Syndrome and Monoclonal Gammopathy with α1 Antitrypsin Deficiency |
| Q50850418 | 5q(-)survival: importance of gender and deleted 5q bands and survival analysis based on 324 published cases. |
| Q33503496 | 5q- in a child with refractory anemia with excess blasts: similarities to 5q- syndrome in adults |
| Q37549908 | 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics. |
| Q73801255 | 5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report |
| Q41392247 | 5q-, twenty-five years later: a synopsis |
| Q36356527 | 5q− anomaly in acute lymphoblastic leukemia |
| Q77175018 | A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome |
| Q33597554 | A constitutional 5q23 deletion |
| Q73950067 | Allelic loss of the FMS gene in acute myeloid leukaemia |
| Q34619840 | Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders |
| Q39758339 | Associations between morphology, karyotype, and clinical features in myeloid leukemias. |
| Q40895768 | Biology and treatment of myelodysplastic syndromes--developments in the past decade |
| Q38908393 | Breakpoints Involved in Deletions of the Long Arm of Chromosome 5 in Myelodysplasia and Acute Non-Lymphoblastic Leukemia do not Correlate with the Morphological Diagnosis |
| Q32168399 | Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint |
| Q40540557 | Chromosomal deletions in myelodysplasia |
| Q36746716 | Chromosomal deletions in the myelodysplastic syndrome |
| Q68218810 | Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance |
| Q36244167 | Clinical Course of Myelodysplastic Syndromes |
| Q37752361 | Closing in on the pathogenesis of the 5q- syndrome |
| Q68780398 | Correlations between cytogenetics and morphology in myelodysplastic syndromes |
| Q71864360 | Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases |
| Q24562724 | Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases |
| Q36468311 | Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases |
| Q72233540 | Cytogenetic findings in 179 patients with myelodysplastic syndromes |
| Q36746725 | Cytogenetic findings in primary and secondary MDS |
| Q38020370 | Cytogenetics in the investigation of haematological disorders |
| Q36244129 | Cytogenetics. |
| Q35533663 | Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system |
| Q28266438 | Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia |
| Q33751348 | Deletion of band 5q21 in association with a de novo translocation involving 2p and 5q. |
| Q37984021 | Disease-associated patterns of disomic chromosomes in hyperhaploid neoplasms |
| Q42662362 | Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia |
| Q40507921 | Epidemiological and etiological aspects of myelodysplastic syndromes |
| Q34086725 | Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics |
| Q34028179 | Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies |
| Q74789121 | FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes |
| Q57382361 | FLT4 Receptor Tyrosine Kinase Gene Mapping to Chromosome Band 5q35 in Relation to the t(2;5), t(5;6), and t(3;5) Translocations |
| Q70804634 | FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction |
| Q38497622 | Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies. |
| Q74801025 | Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies |
| Q57635516 | Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology |
| Q33676661 | Genetic markers on chromosome 7. |
| Q43742432 | Hematologic and clinical features of patients with chromosome 5 monosomy or deletion (5q) |
| Q36417421 | Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway |
| Q84898688 | Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion |
| Q73929383 | Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation |
| Q77413294 | Isolation of yeast artificial chromosomes containing the entire transcriptional unit of the human FGF1 gene: a 720-kb contig spanning human chromosome 5q31.3-->q32 |
| Q68498950 | Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia |
| Q52546921 | Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia. |
| Q34167283 | Localization of the HLA class II-associated invariant chain gene to human chromosome band 5q32. |
| Q24564365 | Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion |
| Q36244146 | Molecular Genetic Aspects of Myelodysplastic Syndromes |
| Q83363860 | Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients |
| Q78141298 | Molecular cytogenetics localizes two new breakpoints on 11q23.3 and 21q11.2 in myelodysplastic syndrome with t(11;21) translocation |
| Q36243996 | Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. |
| Q37937810 | Molecular dissection of the 5q deletion in myelodysplastic syndrome |
| Q74789117 | Molecular features of primary MDS with cytogenetic changes |
| Q34996338 | Molecular pathogenesis of MDS. |
| Q67867794 | Murine Radiation Myeloid Leukaemogenesis: A Possible Role for Radiation-Sensitive Sites on Chromosome 2 |
| Q44125500 | Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan |
| Q50213851 | Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide |
| Q44086082 | Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum |
| Q34842751 | Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene |
| Q50951275 | Nucleophosmin mutation in de-novo acute myeloid leukemia. |
| Q35197625 | Order of genes on human chromosome 5q with respect to 5q interstitial deletions |
| Q41073900 | Pathogenetic Aspects of Myelodysplastic Syndromes |
| Q34053035 | Physical mapping of the minimal region of loss in 5q- chromosome |
| Q36746706 | Prognostic factors in the myelodysplastic syndromes |
| Q37810120 | Prognostic molecular markers in myelodysplastic syndromes |
| Q34381096 | RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes |
| Q33489476 | Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study. |
| Q44613926 | Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia |
| Q40843623 | Risk factors and their relationship to prognosis in myelodysplastic syndromes |
| Q38703999 | Serum-inducible genes |
| Q45204109 | The 5q- syndrome |
| Q40563638 | The 5q- syndrome: a scientific and clinical update |
| Q50472786 | The Evolution of the Ribosomal Protein-MDM2-p53 Pathway. |
| Q28372715 | The benzene metabolites hydroquinone and catechol act in synergy to induce dose-dependent hypoploidy and -5q31 in a human cell line |
| Q35224186 | The cytogenetics of haematological malignancies |
| Q36907039 | The incidence of myelodysplastic syndromes in Western Greece is increasing. |
| Q59529597 | The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology |
| Q24299187 | The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q |
| Q39764629 | The myelodysplastic syndrome--a practical guide |
| Q34637442 | The process of leukemogenesis |
| Q39805247 | The prognostic significance of cytological, histological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts. A follow up study |
| Q34423435 | The pur protein family: genetic and structural features in development and disease |
| Q33735177 | The relationship between the myelodysplastic syndromes and the myeloproliferative disorders |
| Q33378398 | The role of lenalidomide in the management of myelodysplasia with del 5q. |
| Q52531579 | The unexplored 5q13 locus: a role in hematopoietic malignancies. |
| Q31117449 | Thrombopoiesis and Structural Rearrangements of the Long Arm of Chromosome 3. Review arid Analysis of Data on 64 Published Patients |
| Q22254278 | Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs |
| Q50763662 | Transformation into acute basophilic leukaemia in a patient with myelodysplastic syndrome. |
| Q68447894 | Translocation t(11;21)(q24;q11.2) is a new nonrandomly occurring chromosome change in myelodysplastic syndromes |
| Q35746083 | Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features |
| Q56973354 | Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts |
| Q73826921 | [Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes] |
Search more.